$6.14
0.25% today
Nasdaq, Oct 31, 04:49 pm CET
ISIN
CA74319B5027
Symbol
PROF

Profound Medical Corp Stock price

$6.12
+1.23 25.15% 1M
+1.13 22.65% 6M
-1.39 18.51% YTD
-1.33 17.85% 1Y
+1.98 47.83% 3Y
-10.77 63.77% 5Y
-4.07 39.91% 10Y
-4.07 39.91% 20Y
Nasdaq, Closing price Thu, Oct 30 2025
-0.01 0.16%

Key metrics

Basic
Market capitalization
$184.2m
Enterprise Value
$153.8m
Net debt
positive
Cash
$35.2m
Shares outstanding
30.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
15.6 | 10.8
EV/Sales
13.0 | 9.0
EV/FCF
negative
P/B
4.7
Financial Health
Equity Ratio
86.0%
Return on Equity
-46.0%
ROCE
-96.3%
ROIC
-330.2%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$11.8m | $17.1m
EBITDA
$-41.6m | $-42.6m
EBIT
$-42.3m | $-44.8m
Net Income
$-40.7m | $-46.5m
Free Cash Flow
$-34.7m
Growth (TTM | estimate)
Revenue
50.3% | 60.1%
EBITDA
-40.4% | -32.7%
EBIT
-38.0% | -35.4%
Net Income
-47.6% | -67.2%
Free Cash Flow
-57.2%
Margin (TTM | estimate)
Gross
69.4%
EBITDA
-351.0% | -249.4%
EBIT
-357.4%
Net
-344.0% | -272.1%
Free Cash Flow
-293.3%
More
EPS
$-1.4
FCF per Share
$-1.2
Short interest
3.2%
Employees
142
Rev per Employee
$80.0k
Show more

Is Profound Medical Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Profound Medical Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Profound Medical Corp forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Profound Medical Corp forecast:

Buy
83%
Hold
17%

Financial data from Profound Medical Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
12 12
50% 50%
100%
- Direct Costs 3.62 3.62
18% 18%
31%
8.22 8.22
71% 71%
69%
- Selling and Administrative Expenses 31 31
54% 54%
260%
- Research and Development Expense 20 20
27% 27%
167%
-42 -42
40% 40%
-351%
- Depreciation and Amortization 0.76 0.76
29% 29%
6%
EBIT (Operating Income) EBIT -42 -42
38% 38%
-357%
Net Profit -41 -41
48% 48%
-344%

In millions USD.

Don't miss a Thing! We will send you all news about Profound Medical Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Profound Medical Corp Stock News

Neutral
GlobeNewsWire
17 days ago
TORONTO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company's business at the Stifel 2025 Healthcare Conference ...
Neutral
GlobeNewsWire
24 days ago
To release full third quarter 2025 financial results on November 13th; conference call to follow To release full third quarter 2025 financial results on November 13th; conference call to follow
Neutral
GlobeNewsWire
about one month ago
New program delivers TULSA Procedure's precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across Texas New program delivers TULSA Procedure's precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across Texas
More Profound Medical Corp News

Company Profile

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.

Head office Canada
CEO Arun Menawat
Employees 142
Founded 2008
Website profoundmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today